Viewing Study NCT00413218

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:34 AM
Ignite Modification Date: 2026-05-13 @ 10:39 PM
Study NCT ID: NCT00413218
Status: COMPLETED
Last Update Posted: 2024-12-10
First Post: 2006-12-18
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
Sponsor: Astellas Pharma Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Candidemia View
None Mycoses View
None Candidiasis, Invasive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Invasive Candida infections View
None BAL8557 View
None ASP9766 View
None Isavuconazole View
None Candidemia View
None Candidemia and other invasive candida infections View
None Phase III study View